Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | Director | June 10, 2025 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date June 10, 2025 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 650,062 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 32,012 · Balance 650,062 F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 24,802 |
Reported balance
Holding disclosure · report date 2025-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 24,802 F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy the Charlotte G. Berkowitz 2016 Trust | 146,575 |
Reported balance
Holding disclosure · report date 2025-06-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 146,575 F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. F3: As one of two trustees of the identified trust, the reporting person may be deemed to be the beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | IndirectBy the Thomas G. Berkowitz 2016 Trust | 146,575 |
Reported balance
Holding disclosure · report date 2025-06-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 146,575 F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. F3: As one of two trustees of the identified trust, the reporting person may be deemed to be the beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | IndirectBy the Hayward M. Berkowitz 2016 Trust | 146,575 |
Reported balance
Holding disclosure · report date 2025-06-10 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 146,575 F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. F3: As one of two trustees of the identified trust, the reporting person may be deemed to be the beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | IndirectBy the William W. Berkowitz 2016 Trust | 146,575 |
Reported balance
Holding disclosure · report date 2025-06-10 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 146,575 F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. F3: As one of two trustees of the identified trust, the reporting person may be deemed to be the beneficial owner of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.
F2: The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
F3: As one of two trustees of the identified trust, the reporting person may be deemed to be the beneficial owner of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 32,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001364333-26-000002 · form4-06122026_050601.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650,062 F1 · security: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 23:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 62,500 | $15.97 | $998,125.00 |
DisclosureSEC source: 0001415889-25-024313 · form4-09112025_070901.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,050 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 15,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017261 · form4-06132025_050601.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 680,550 F1 · security: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 16,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016932 · form4-06142024_040618.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 665,419 F1 · security: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 23:56 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 9,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010112 · form4-06212023_110637.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 648,672 F1 · security: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 12, 2023 Filed May 12, 2023 22:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionWarrants (right to buy) · Derivative | 107,937 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001415889-23-007923 · form4-05122023_100550.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,937 shares Expires 2023-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2023 Filed May 12, 2023 22:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Tax withholdingCommon Stock | 24,294 | $15.55 | $377,771.70 |
DisclosureSEC source: 0001415889-23-007923 · form4-05122023_100550.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,764 F1 · kind: On May 12, 2023, the reporting person exercised warrants to purchase 107,937 shares of the issuer's common stock for $3.50 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 24,294 of the warrant shares to pay the exercise price and issuing to the reporting person 83,643 shares. Read SEC document |
| May 12, 2023 Filed May 12, 2023 22:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 107,937 | $3.50 | $377,779.50 |
DisclosureSEC source: 0001415889-23-007923 · form4-05122023_100550.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 20:29 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionWarrants (right to buy) · Derivative | 107,937 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001415889-23-004574 · form4-03092023_080311.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 0 Underlying: Common Stock · 107,937 shares Expires 2023-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 20:29 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Tax withholdingCommon Stock | 23,820 | $15.86 | $377,785.20 |
DisclosureSEC source: 0001415889-23-004574 · form4-03092023_080311.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 611,102 F1 · kind: On March 7, 2023, the reporting person exercised warrants to purchase 107,937 shares of the issuer's common stock for $3.50 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 23,820 of the warrant shares to pay the exercise price and issuing to the reporting person 84,117 shares. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 20:29 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 107,937 | $3.50 | $377,779.50 |
DisclosureSEC source: 0001415889-23-004574 · form4-03092023_080311.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 634,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 23:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Reporting Person is the managing member of Porcupine Investment Partners, LLC and may be deemed to beneficially own the securities held by Porcupine Investment Partners, LLC. Reporting Person, however, disclaims beneficial ownership of such securities except as to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 23:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 200,000 | $2.00 | $400,000.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 526,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Reporting Person is the managing member of Porcupine Investment Partners, LLC and may be deemed to beneficially own the securities held by Porcupine Investment Partners, LLC. Reporting Person, however, disclaims beneficial ownership of such securities except as to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 15:59 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 16,000 | $7.20 | $115,200.00 |
DisclosureSEC source: 0001179110-22-003286 · edgar.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,121 F1 · ownership.direct: Includes shares owned by Reporting Person and shares owned by Reporting Person's spouse. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 23:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · derivative · entry 3 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 23:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 200,000 | $2.00 | $400,000.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Includes shares owned by Reporting Person and shares owned by Reporting Person's spouse. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 8,396 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-017196 · doc4.xml · nonDerivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,121 F1 · kind: This Form 4 is being filed to report (a) the pro rata distribution of 906,431 shares of the Issuer's common stock by HealthpointCapital Partners, L.P. to its limited partners for no consideration (the "Fund I Distribution"); (b) the pro rata distribution of 1,742,546 shares of the Issuer's common stock by HealthpointCapital Partners II, L.P. to its limited partners for no consideration (the "Fund II Distribution"); (c) the receipt of 2,807 shares of the Issuer's common stock by the Reporting Person in the Fund I Distribution as a limited partner of HealthpointCapital Partners, L.P.; and (d) the receipt of 8,396 shares of the Issuer's common stock by the Reporting Person in the Fund II Distribution as a limited partner of HealthpointCapital Partners II, L.P. F3 · balance_after: Includes shares owned by the Reporting Person and shares owned by the Reporting Person's spouse. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 2,807 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-017196 · doc4.xml · nonDerivative · entry 3 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,725 F1 · kind: This Form 4 is being filed to report (a) the pro rata distribution of 906,431 shares of the Issuer's common stock by HealthpointCapital Partners, L.P. to its limited partners for no consideration (the "Fund I Distribution"); (b) the pro rata distribution of 1,742,546 shares of the Issuer's common stock by HealthpointCapital Partners II, L.P. to its limited partners for no consideration (the "Fund II Distribution"); (c) the receipt of 2,807 shares of the Issuer's common stock by the Reporting Person in the Fund I Distribution as a limited partner of HealthpointCapital Partners, L.P.; and (d) the receipt of 8,396 shares of the Issuer's common stock by the Reporting Person in the Fund II Distribution as a limited partner of HealthpointCapital Partners II, L.P. F3 · balance_after: Includes shares owned by the Reporting Person and shares owned by the Reporting Person's spouse. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 1,742,546 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-017196 · doc4.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held By HealthpointCapital Partners II, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 is being filed to report (a) the pro rata distribution of 906,431 shares of the Issuer's common stock by HealthpointCapital Partners, L.P. to its limited partners for no consideration (the "Fund I Distribution"); (b) the pro rata distribution of 1,742,546 shares of the Issuer's common stock by HealthpointCapital Partners II, L.P. to its limited partners for no consideration (the "Fund II Distribution"); (c) the receipt of 2,807 shares of the Issuer's common stock by the Reporting Person in the Fund I Distribution as a limited partner of HealthpointCapital Partners, L.P.; and (d) the receipt of 8,396 shares of the Issuer's common stock by the Reporting Person in the Fund II Distribution as a limited partner of HealthpointCapital Partners II, L.P. F2 · ownership.nature: The Reporting Person is a managing member of HGP LLC, which is the general partner of HealthpointCapital Partners, L.P. In addition, the Reporting Person is a managing member of HGP II, LLC, which is the general partner of HealthpointCapital Partners II, L.P. As such, the Reporting Person may be deemed to beneficially own the securities held by HealthpointCapital Partners, L.P. and HealthpointCapital Partners II, L.P. The Reporting Person, however, disclaims beneficial ownership of such shares except as to the extent of his pecuniary interest therein. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | OtherCommon Stock | 906,431 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-017196 · doc4.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held By HealthpointCapital Partners, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 is being filed to report (a) the pro rata distribution of 906,431 shares of the Issuer's common stock by HealthpointCapital Partners, L.P. to its limited partners for no consideration (the "Fund I Distribution"); (b) the pro rata distribution of 1,742,546 shares of the Issuer's common stock by HealthpointCapital Partners II, L.P. to its limited partners for no consideration (the "Fund II Distribution"); (c) the receipt of 2,807 shares of the Issuer's common stock by the Reporting Person in the Fund I Distribution as a limited partner of HealthpointCapital Partners, L.P.; and (d) the receipt of 8,396 shares of the Issuer's common stock by the Reporting Person in the Fund II Distribution as a limited partner of HealthpointCapital Partners II, L.P. F2 · ownership.nature: The Reporting Person is a managing member of HGP LLC, which is the general partner of HealthpointCapital Partners, L.P. In addition, the Reporting Person is a managing member of HGP II, LLC, which is the general partner of HealthpointCapital Partners II, L.P. As such, the Reporting Person may be deemed to beneficially own the securities held by HealthpointCapital Partners, L.P. and HealthpointCapital Partners II, L.P. The Reporting Person, however, disclaims beneficial ownership of such shares except as to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2018 Filed May 21, 2018 23:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionSeries B Convertible Preferred Stock · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007279 · edgar.xml · derivative · entry 6 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 0 Underlying: Common Stock · 126,985 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. Read SEC document |
| May 17, 2018 Filed May 21, 2018 23:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionSeries B Convertible Preferred Stock · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007279 · edgar.xml · derivative · entry 5 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 126,985 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. Read SEC document |
| May 17, 2018 Filed May 21, 2018 23:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 126,985 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007279 · edgar.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 326,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. Read SEC document |
| May 17, 2018 Filed May 21, 2018 23:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 126,985 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007279 · edgar.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B Convertible Preferred Stock had no expiration date and converted into 317.4603 shares of the issuer's common stock on May 17, 2018, the date that issuer's stockholders approved such conversion. F2 · balance_after: Includes shares owned by Reporting Person and shares owned by Reporting Person's spouse. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantWarrants (right to buy) · Derivative | 107,937 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001179110-18-004101 · edgar.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 107,937 Underlying: Common Stock · 107,937 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantWarrants (right to buy) · Derivative | 107,937 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001179110-18-004101 · edgar.xml · derivative · entry 3 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,937 Underlying: Common Stock · 107,937 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following the date that stockholder approval is obtained. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantSeries B Convertible Preferred Stock · Derivative | 400 | $1,000.00 | $400,000.00 |
DisclosureSEC source: 0001179110-18-004101 · edgar.xml · derivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 400 Underlying: Common Stock · 126,985 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantSeries B Convertible Preferred Stock · Derivative | 400 | $1,000.00 | $400,000.00 |
DisclosureSEC source: 0001179110-18-004101 · edgar.xml · derivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 126,985 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. F1 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock has no expiration date and is convertible into 317.4603 shares of the issuer's common stock following the date that stockholder approval is obtained. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:31 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionSeries A Convertible Preferred Stock · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013566 · edgar.xml · derivative · entry 6 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Porcupine Investment Partners, LLC Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. F3 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:31 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionSeries A Convertible Preferred Stock · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013566 · edgar.xml · derivative · entry 5 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. F3 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the Issuer's common stock following the date that shareholders approve such conversion, which approval was obtained on June 15, 2017. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:31 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013566 · edgar.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held By Porcupine Investment Partners, LLC Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:31 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | Exercise / conversionCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013566 · edgar.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares owned by Reporting Person and shares owned by Reporting Person's spouse. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 3 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F2 · derivative.exercise_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. F2 · derivative.expiration_date: Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantSeries A Convertible Preferred Stock · Derivative | 400 | $1,000.00 Strike: $2.00 | $400,000.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 400 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:41 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantSeries A Convertible Preferred Stock · Derivative | 400 | $1,000.00 Strike: $2.00 | $400,000.00 |
DisclosureSEC source: 0000899243-17-009014 · doc4.xml · derivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock has no expiration date and is convertible into 500 shares of the issuer's common stock following that date that shareholder approval is obtained. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.